G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in G1 Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +7 vs. Q2 2022
- Shares held
- 23.1M
- +3.21M (+16.2%) vs. Q2 2022
- Total value
- $287.5M
- +$189.3M (+192.9%) vs. Q2 2022
- New holders
- 25
- 42 more added
- Sold out
- 18
- 18 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTHX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 88 | $45.5M |
| Q1 2024 | 86 | $61.6M |
| Q4 2023 | 87 | $38.5M |
| Q3 2023 | 72 | $15.8M |
| Q2 2023 | 80 | $38.6M |
| Q1 2023 | 97 | $51.5M |
| Q4 2022 | 116 | $125.1M |
| Q3 2022 | 104 | $287.5M |
| Q2 2022 | 98 | $98.2M |
| Q1 2022 | 115 | $183.8M |
| Q4 2021 | 108 | $270.6M |
| Q3 2021 | 115 | $357.8M |
| Q2 2021 | 114 | $541.8M |
| Q1 2021 | 123 | $582.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding G1 Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 1,618,381 | $20.2M | 0.00% | +1,476,175+1,038.1% | Added |
| Vanguard Group Inc | 1,686,453 | $21.1M | 0.00% | +65,952+4.1% | Added |
| JPMorgan Chase & Co | 2,043,773 | $25.5M | 0.00% | −85,676−4.0% | Reduced |
| Fisher Asset Management, LLC | 2,935,332 | $36.7M | 0.03% | +626,777+27.2% | Added |
| Ergoteles LLC | 0 | $0 | 0.00% | −220,100−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −179,472−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −131,600−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −72,347−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −28,394−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −25,220−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −23,800−100.0% | Sold out |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 0 | $0 | 0.00% | −14,195−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −21,388−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,578−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −17,100−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −12,656−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,737−100.0% | Sold out |
| Golden Green, Inc. | 0 | $0 | 0.00% | −11,220−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −10,772−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |